Correlation Between Johnson Johnson and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Mersana Therapeutics, you can compare the effects of market volatilities on Johnson Johnson and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Mersana Therapeutics.
Diversification Opportunities for Johnson Johnson and Mersana Therapeutics
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Johnson and Mersana is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Johnson Johnson and Mersana Therapeutics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.13 times more return on investment than Mersana Therapeutics. However, Johnson Johnson is 7.71 times less risky than Mersana Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about -0.2 per unit of risk. If you would invest 14,220 in Johnson Johnson on December 28, 2024 and sell it today you would earn a total of 2,093 from holding Johnson Johnson or generate 14.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. Mersana Therapeutics
Performance |
Timeline |
Johnson Johnson |
Mersana Therapeutics |
Johnson Johnson and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and Mersana Therapeutics
The main advantage of trading using opposite Johnson Johnson and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements |